Related Experiment Video

Updated: Dec 27, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.1K

Role of STAT3 signaling pathway in breast cancer

Jia-Hui Ma1, Li Qin2,3, Xia Li4,5

  • 1Marine College, Shandong University, Wenhua West Rd. 180, Weihai, Shandong, 264209, P.R. China.

Cell Communication and Signaling : CCS
|March 1, 2020
PubMed

Insights

New research highlights Signal transducer and activator of transcription 3 (STAT3) as a key target for breast cancer treatment. Inhibiting STAT3 shows promise in overcoming chemoresistance and improving therapeutic outcomes for this deadly disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Breast cancer is a leading cause of cancer deaths in women, with limited treatment options due to chemoresistance.
  • Signal transducer and activator of transcription 3 (STAT3) is implicated in breast cancer malignancy, progression, and chemoresistance.
  • Overexpressed and activated STAT3 pathways are crucial in breast cancer development and metastasis.

Purpose of the Study:

  • To review recent advances in understanding STAT3 pathways in breast cancer.
  • To discuss the development of small molecule inhibitors targeting STAT3 for therapeutic applications.
  • To highlight novel therapeutic strategies for breast cancer treatment.

Main Methods:

  • Systematic review of clinical and preclinical data.
  • Analysis of studies on STAT3 pathway discovery and drug development.
  • Evaluation of STAT3 inhibitors' efficacy in breast cancer models.

Main Results:

  • STAT3 plays a significant role in breast cancer progression, proliferation, metastasis, and chemoresistance.
  • New upstream regulators and downstream targets of STAT3 have been identified.
  • Small molecule inhibitors targeting STAT3 activation demonstrate therapeutic potential.

Conclusions:

  • Targeting STAT3 pathways offers a promising strategy to overcome chemoresistance in breast cancer.
  • Further research into STAT3 inhibitors could lead to more effective breast cancer treatments.
  • STAT3 is a critical therapeutic target for improving breast cancer patient outcomes.
Keywords:
Breast cancerOncogeneSTAT3Small molecule inhibitors

More Related Videos

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells09:32

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

9.5K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

754

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K